| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |